Broadcom’s (AVGO) Buy Rating Reaffirmed at Mizuho

Share on StockTwits

Mizuho restated their buy rating on shares of Broadcom (NASDAQ:AVGO) in a research report sent to investors on Friday, The Fly reports. They currently have a $340.00 price objective on the semiconductor manufacturer’s stock, up from their prior price objective of $330.00.

Several other brokerages have also recently weighed in on AVGO. Robert W. Baird dropped their target price on Broadcom from $300.00 to $280.00 and set an outperform rating for the company in a report on Monday, June 17th. JPMorgan Chase & Co. decreased their target price on Broadcom from $365.00 to $350.00 and set an overweight rating for the company in a research report on Friday, June 14th. DA Davidson decreased their target price on Broadcom to $300.00 and set a buy rating for the company in a research report on Friday, June 14th. Loop Capital set a $310.00 price target on Broadcom and gave the stock a buy rating in a research note on Monday, September 9th. Finally, KeyCorp increased their target price on Broadcom from $310.00 to $330.00 and gave the company an overweight rating in a research note on Friday, August 9th. Ten equities research analysts have rated the stock with a hold rating and thirty have assigned a buy rating to the stock. The stock presently has a consensus rating of Buy and an average price target of $311.71.

Broadcom stock opened at $288.66 on Friday. Broadcom has a 52 week low of $208.23 and a 52 week high of $323.20. The business has a 50-day simple moving average of $282.27 and a 200 day simple moving average of $287.04. The company has a quick ratio of 1.13, a current ratio of 1.26 and a debt-to-equity ratio of 1.53. The stock has a market cap of $119.65 billion, a price-to-earnings ratio of 15.33, a PEG ratio of 1.47 and a beta of 0.88.

Broadcom (NASDAQ:AVGO) last posted its earnings results on Thursday, September 12th. The semiconductor manufacturer reported $3.99 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $4.10 by ($0.11). Broadcom had a return on equity of 33.21% and a net margin of 13.44%. The business had revenue of $5.52 billion for the quarter, compared to analysts’ expectations of $5.52 billion. During the same quarter in the previous year, the firm earned $4.98 earnings per share. Broadcom’s quarterly revenue was up 8.9% compared to the same quarter last year. On average, research analysts anticipate that Broadcom will post 17.23 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Investors of record on Monday, September 23rd will be paid a $2.65 dividend. This represents a $10.60 dividend on an annualized basis and a yield of 3.67%. The ex-dividend date is Friday, September 20th. Broadcom’s dividend payout ratio (DPR) is 56.29%.

In related news, CEO Hock E. Tan sold 20,000 shares of the business’s stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $270.46, for a total value of $5,409,200.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Bryan Ingram sold 13,466 shares of the business’s stock in a transaction that occurred on Wednesday, June 19th. The stock was sold at an average price of $278.78, for a total transaction of $3,754,051.48. The disclosure for this sale can be found here. Insiders sold 65,388 shares of company stock valued at $18,327,682 in the last three months. 3.30% of the stock is currently owned by insiders.

A number of large investors have recently modified their holdings of AVGO. Nuveen Asset Management LLC raised its stake in Broadcom by 2,421.3% in the second quarter. Nuveen Asset Management LLC now owns 3,410,706 shares of the semiconductor manufacturer’s stock worth $981,806,000 after buying an additional 3,275,431 shares in the last quarter. Point72 Asset Management L.P. increased its position in shares of Broadcom by 1,808.4% during the second quarter. Point72 Asset Management L.P. now owns 777,480 shares of the semiconductor manufacturer’s stock worth $223,805,000 after purchasing an additional 736,741 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Broadcom by 1.8% during the second quarter. Vanguard Group Inc. now owns 31,797,832 shares of the semiconductor manufacturer’s stock worth $9,153,324,000 after purchasing an additional 559,961 shares in the last quarter. Thoroughbred Financial Services LLC increased its position in shares of Broadcom by 40,641.1% during the second quarter. Thoroughbred Financial Services LLC now owns 514,967 shares of the semiconductor manufacturer’s stock worth $51,497,000 after purchasing an additional 513,703 shares in the last quarter. Finally, Natixis increased its position in shares of Broadcom by 840.6% during the second quarter. Natixis now owns 440,738 shares of the semiconductor manufacturer’s stock worth $126,871,000 after purchasing an additional 393,880 shares in the last quarter. 84.57% of the stock is owned by institutional investors.

Broadcom Company Profile

Broadcom Inc designs, develops, and supplies a range of semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. The company operates through four segments: Wired Infrastructure, Wireless Communications, Enterprise Storage, and Industrial & Other.

Further Reading: What is a back-end load?

The Fly

Analyst Recommendations for Broadcom (NASDAQ:AVGO)

Receive News & Ratings for Broadcom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Broadcom and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Dunelm Group  Stock Rating Upgraded by Peel Hunt
Dunelm Group Stock Rating Upgraded by Peel Hunt
Barclays Downgrades Ferrexpo  to Underweight
Barclays Downgrades Ferrexpo to Underweight
UBS Group Reaffirms “Neutral” Rating for Halma
UBS Group Reaffirms “Neutral” Rating for Halma
Schneider National  Raised to Buy at UBS Group
Schneider National Raised to Buy at UBS Group
Investment Analysts’ Recent Ratings Updates for Mirati Therapeutics
Investment Analysts’ Recent Ratings Updates for Mirati Therapeutics
Sunoco  Upgraded at ValuEngine
Sunoco Upgraded at ValuEngine


 
© 2006-2019 Zolmax.